Ferring Pharmaceuticals | Sustainability Performance
A global biopharmaceutical company focused on research and development in areas such as reproductive medicine, maternal health, gastroenterology, and urology.
1950
Switzerland
5,001 - 10,000 employees
Pharmaceuticals
$25M - 100M in revenue
Sustainability Ranking & Industry Benchmark
#2551
Overall#86
in Switzerland#58
in PharmaceuticalsSustainability Maturity
Sustainability Intent
Overview
Governance
Targets
Controversy level
- Ferring Pharmaceuticals faced the 2017 Bravelle fertility drug global recall over inadequate potency followed by multicountry class actions, plus the historic Adstiladrin bladder cancer treatment supply disruption affecting US oncology customers.
Sustainability targets and commitments
| Target | Year | Value | Scope | Baseline |
|---|
